"Correction to “ß Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves ß2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia”." Journal of Pharmacology and Experimental Therapeutics
369.1
(2019):
65.
Web. 19 April. 2024.